Skandinaviska Enskilda Banken (SEB) Portfolio holdings
AUM
$23B
This Quarter Return
+1.3%
1 Year Return
+23.43%
3 Year Return
+116.09%
5 Year Return
+203.29%
10 Year Return
–
AUM
$18.2B
AUM Growth
+$18.2B
(+12%)
Cap. Flow
+$2.18B
Cap. Flow
% of AUM
11.94%
Top 10 Holdings %
Top 10 Hldgs %
25.35%
Holding
1,139
New
94
Increased
388
Reduced
363
Closed
119
Top Buys
| 1 |
Microsoft
MSFT
|
$249M |
| 2 |
Netflix
NFLX
|
$168M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$154M |
| 4 |
NVIDIA
NVDA
|
$147M |
| 5 |
Qualcomm
QCOM
|
$126M |
Top Sells
| 1 |
Merck
MRK
|
$61.7M |
| 2 |
Alibaba
BABA
|
$45.1M |
| 3 |
Tesla
TSLA
|
$43.4M |
| 4 |
Oracle
ORCL
|
$40M |
| 5 |
Clorox
CLX
|
$38.8M |
Sector Composition
| 1 | Technology | 28.28% |
| 2 | Healthcare | 19.45% |
| 3 | Financials | 12.65% |
| 4 | Communication Services | 10.62% |
| 5 | Consumer Discretionary | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Weyerhaeuser
WY
$18.7B
| $125M | 0.69% | 3,521,453 +654,304 | +23% | +$23.3M |
|
27
Verizon
VZ
$186B
| $122M | 0.67% | 2,259,937 +31,536 | +1% | +$1.7M |
|
28
Hershey
HSY
$37.3B
| $115M | 0.63% | 679,522 +370,564 | +120% | +$62.7M |
|
29
Eli Lilly
LLY
$657B
| $112M | 0.62% | 486,511 +11,062 | +2% | +$2.56M |
|
30
Bristol-Myers Squibb
BMY
$96B
| $111M | 0.61% | 1,870,229 -295,761 | -14% | -$17.5M |
|
31
Thermo Fisher Scientific
TMO
$186B
| $110M | 0.6% | 192,118 -5,418 | -3% | -$3.1M |
|
32
Applied Materials
AMAT
$128B
| $104M | 0.57% | 804,333 +111,924 | +16% | +$14.4M |
|
33
Mastercard
MA
$538B
| $103M | 0.57% | 297,106 +16,438 | +6% | +$5.72M |
|
34
Intel
INTC
$107B
| $102M | 0.56% | 1,917,190 +110,245 | +6% | +$5.87M |
|
35
Colgate-Palmolive
CL
$67.9B
| $101M | 0.56% | 1,339,769 +45,033 | +3% | +$3.4M |
|
36
Interpublic Group of Companies
IPG
$9.83B
| $99.9M | 0.55% | 2,724,153 +2,583,775 | +1,841% | +$94.7M |
|
37
AbbVie
ABBV
$372B
| $99.3M | 0.54% | 919,580 +64,034 | +7% | +$6.92M |
|
38
Bank of America
BAC
$376B
| $97.7M | 0.54% | 2,300,421 -701 | -0% | -$29.8K |
|
39
CBRE Group
CBRE
$48.2B
| $97.4M | 0.53% | 1,000,808 +248,493 | +33% | +$24.2M |
|
40
Moderna
MRNA
$9.37B
| $93.8M | 0.51% | 243,603 +103,910 | +74% | +$40M |
|
41
Lowe's Companies
LOW
$145B
| $91.2M | 0.5% | 449,332 +24,477 | +6% | +$4.97M |
|
42
HP
HPQ
$26.7B
| $91.1M | 0.5% | 3,327,844 +948,419 | +40% | +$25.9M |
|
43
Goldman Sachs
GS
$226B
| $90.9M | 0.5% | 240,403 +113,095 | +89% | +$42.8M |
|
44
PepsiCo
PEP
$204B
| $90.2M | 0.49% | 599,896 -75,185 | -11% | -$11.3M |
|
45
Danaher
DHR
$147B
| $81.3M | 0.45% | 267,126 +3,273 | +1% | +$996K |
|
46
HCA Healthcare
HCA
$94.5B
| $80.4M | 0.44% | 331,312 -102,418 | -24% | -$24.9M |
|
47
Quest Diagnostics
DGX
$20.3B
| $79.5M | 0.44% | 547,088 +113,286 | +26% | +$16.5M |
|
48
Wells Fargo
WFC
$263B
| $78.9M | 0.43% | 1,696,423 +868,256 | +105% | +$40.4M |
|
49
Owens Corning
OC
$12.6B
| $78.7M | 0.43% | 920,385 +559,700 | +155% | +$47.9M |
|
50
Abbott
ABT
$231B
| $77.7M | 0.43% | 657,833 -3,147 | -0.5% | -$372K |
|